相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Blockbuster dreams for Pfizer's CDK inhibitor
Malini Guha
NATURE BIOTECHNOLOGY (2013)
The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer
Mohammad Al Sorkhy et al.
BMC CANCER (2012)
Spy1 Is Frequently Overexpressed in Malignant Gliomas and Critically Regulates the Proliferation of Glioma Cells
Li Zhang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells
Binoj C. Nair et al.
BREAST CANCER RESEARCH (2011)
Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma
Qing Ke et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model
Maria Virginia C. L. Appleyard et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The Cyclin-dependent Kinase Activator, Spy1A, Is Targeted for Degradation by the Ubiquitin Ligase NEDD4
Mohammad Al Sorkhy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis
Azadeh Golipour et al.
CANCER RESEARCH (2008)
Lentiviral Transduction of Mammary Stem Cells for Analysis of Gene Function during Development and Cancer
Bryan E. Welm et al.
Cell Stem Cell (2008)
CDK inhibitors in cancer therapy: what is next?
Marcos Malumbres et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Spy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27
Christopher W. McAndrew et al.
CELL CYCLE (2007)
Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor β resistance and acquire paracrine mitogenic stimulation during progression
Patrick Corsino et al.
CANCER RESEARCH (2007)
Spy1 expression prevents normal cellular responses to DNA damage - Inhibition of apoptosis and checkpoint activation
Randy F. Gastwirt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2
D Ungermannova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins
A Cheng et al.
CELL CYCLE (2005)
Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis
I Zucchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Molecular and biochemical characterization of the Skp2-Cks1 binding interface
W Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
p27 deregulation in breast cancer: Prognostic significance and implications for therapy
A Alkarain et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2004)
Spy1 interacts with p27Kip1 to allow G1/S progression
LA Porter et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Cyclin dependent kinases and cell cycle control
PM Nurse
BIOSCIENCE REPORTS (2002)
Three different binding sites of Cks1 are required for p27-ubiquitin ligation
D Sitry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2
LA Porter et al.
JOURNAL OF CELL BIOLOGY (2002)